INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:INSP - US4577301090 - Common Stock
96.2 USD
+1.75 (+1.85%)
96.68 USD
+0.48 (+0.5%)
ChartMill assigns a Buy % Consensus number of 80% to INSP. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 142.79. This target is 48.43% above the current price.
- INSP was analyzed by 25 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about INSP.
- In the previous month the buy percentage consensus was at a similar level.
- INSP was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-23 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-12-16 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-12-08 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2025-12-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-12-04 | Baird | Maintains | Outperform -> Outperform |
| 2025-12-02 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-11-26 | Truist Securities | Upgrade | Hold -> Buy |
| 2025-11-25 | Wolfe Research | Upgrade | Peer Perform -> Outperform |
| 2025-11-24 | Stifel | Upgrade | Hold -> Buy |
| 2025-11-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-04 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-11-04 | Truist Securities | Reiterate | Hold -> Hold |
| 2025-11-04 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-04 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-10-24 | Jefferies | Downgrade | Buy -> Hold |
| 2025-10-15 | Truist Securities | Maintains | Hold -> Hold |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-09-22 | UBS | Downgrade | Buy -> Neutral |
| 2025-09-02 | Evercore ISI Group | Initiate | Outperform |
| 2025-08-15 | Leerink Partners | Maintains | Market Perform -> Market Perform |
| 2025-08-05 | Lake Street | Maintains | Buy -> Buy |
| 2025-08-05 | UBS | Maintains | Buy -> Buy |
| 2025-08-05 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2025-08-05 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-08-05 | Stifel | Maintains | Hold -> Hold |
| 2025-08-05 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What is the average price target for INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
25 analysts have analysed INSP and the average price target is 142.79 USD. This implies a price increase of 48.43% is expected in the next year compared to the current price of 96.2.
Can you provide the consensus rating for INSPIRE MEDICAL SYSTEMS INC stock?
The consensus rating for INSPIRE MEDICAL SYSTEMS INC (INSP) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.